Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05867316 · ClinicalTrials.gov registry record · NA

Supplementing Brief Psychotherapy With a Mobile App

A NA study of Emotion Regulation and Suicide and Self-harm, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05867316 is a NA study of Emotion Regulation and Suicide and Self-harm that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 40 participants, below the 200-participant average among 25 other Emotion Regulation trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05867316, a NA study of Emotion Regulation and Suicide and Self-harm, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Suicide is among the leading causes of death worldwide, and the risk of suicide is highest in the period immediately following discharge from inpatient psychiatric care.1Importantly, despite the enormously elevated risk during this period, nearly 50% of patients do not attend scheduled therapy after discharge. Even among those who do attend therapy, however, the skills learned in treatment may be difficult to use during the highly distressing time leading up to and during a suicide crisis. Most traditional treatments are not designed to be effective during a suicide crisis. In order to reduce the risk of suicidal thoughts and behaviors in general and specifically during the post-discharge period, interventions are needed that: (1) are easily adhered to and (2) are accessible and effective during a suicide crisis. As such, the purpose of this research study is to test an innovative, new intervention in order to develop an effective and accessible intervention for those at high risk for suicide

Interventions

  • BEHAVIORAL Unified Protocol

Study Locations (1)

New Jersey

  • Rutgers University Behavioral Healthcare - Piscataway

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-09-14
Est. Completion 2024-06-06
Phase NA

What the Registry Record Tells You About NCT05867316

The ClinicalTrials.gov registry entry for NCT05867316 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 200-participant average among 25 other Emotion Regulation trials with a reported enrollment target (80% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Emotion Regulation appearing as the primary indexed condition, and to 1 intervention - of which Unified Protocol is the first listed.

NCT05867316 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT05867316 about?

NCT05867316 is a clinical study titled "Supplementing Brief Psychotherapy With a Mobile App". Suicide is among the leading causes of death worldwide, and the risk of suicide is highest in the period immediately following discharge from inpatient psychiatric care.1Importantly, despite the enormously elevated risk during this period, nearly 50% of patients do not attend scheduled therapy after...

What is the current status of trial NCT05867316?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-09-14. Estimated completion is 2024-06-06.

What conditions does trial NCT05867316 study?

This clinical trial studies the following conditions: Emotion Regulation, Suicide and Self-harm.

What interventions are being tested in trial NCT05867316?

The interventions under investigation include: Unified Protocol (BEHAVIORAL).

Who is sponsoring clinical trial NCT05867316?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05867316 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Emotion Regulation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.